Dolby Laboratories, Inc. Logo

Dolby Laboratories, Inc.

DLB

(2.2)
Stock Price

72,61 USD

8.35% ROA

8.58% ROE

40.82x PER

Market Cap.

8.136.908.498,00 USD

2.15% DER

1.3% Yield

15.44% NPM

Dolby Laboratories, Inc. Stock Analysis

Dolby Laboratories, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Dolby Laboratories, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (2%), which means it has a small amount of debt compared to the ownership it holds

2 Dividend Growth

Investors can be encouraged by the company's strong dividend growth over the past five years, highlighting its ability to generate consistent returns and provide an attractive investment opportunity.

3 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

4 ROE

The stock's ROE falls within an average range (9.48%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (9.12%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (472) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

7 PBV

The stock's elevated P/BV ratio (3.3x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

10 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

11 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

Dolby Laboratories, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Dolby Laboratories, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Dolby Laboratories, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Dolby Laboratories, Inc. Revenue
Year Revenue Growth
2001 124.653.000
2002 161.868.000 22.99%
2003 217.472.000 25.57%
2004 289.041.000 24.76%
2005 327.967.000 11.87%
2006 391.542.000 16.24%
2007 482.028.000 18.77%
2008 640.231.000 24.71%
2009 719.503.000 11.02%
2010 922.713.000 22.02%
2011 955.505.000 3.43%
2012 926.264.000 -3.16%
2013 909.674.000 -1.82%
2014 960.176.000 5.26%
2015 967.410.000 0.75%
2016 1.025.738.000 5.69%
2017 1.081.454.000 5.15%
2018 1.171.924.000 7.72%
2019 1.241.620.000 5.61%
2020 1.161.792.000 -6.87%
2021 1.281.256.000 9.32%
2022 1.253.793.000 -2.19%
2023 1.162.248.000 -7.88%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Dolby Laboratories, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 16.106.000
2002 15.128.000 -6.46%
2003 18.262.000 17.16%
2004 23.479.000 22.22%
2005 30.532.000 23.1%
2006 35.377.000 13.7%
2007 44.109.000 19.8%
2008 62.080.000 28.95%
2009 66.710.000 6.94%
2010 104.978.000 36.45%
2011 123.920.000 15.29%
2012 140.143.000 11.58%
2013 168.746.000 16.95%
2014 183.128.000 7.85%
2015 200.892.000 8.84%
2016 219.607.000 8.52%
2017 233.312.000 5.87%
2018 236.794.000 1.47%
2019 237.871.000 0.45%
2020 239.045.000 0.49%
2021 253.640.000 5.75%
2022 261.174.000 2.88%
2023 281.704.000 7.29%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Dolby Laboratories, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 119.353.000 100%
2011 137.633.000 13.28%
2012 149.175.000 7.74%
2013 161.970.000 7.9%
2014 178.104.000 9.06%
2015 181.981.000 2.13%
2016 168.854.000 -7.77%
2017 171.686.000 1.65%
2018 197.516.000 13.08%
2019 205.425.000 3.85%
2020 219.753.000 6.52%
2021 224.161.000 1.97%
2022 275.315.000 18.58%
2023 266.448.000 -3.33%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Dolby Laboratories, Inc. EBITDA
Year EBITDA Growth
2001 9.861.000
2002 89.023.000 88.92%
2003 56.694.000 -57.02%
2004 76.715.000 26.1%
2005 91.363.000 16.03%
2006 138.725.000 34.14%
2007 200.238.000 30.72%
2008 311.842.000 35.79%
2009 394.339.000 20.92%
2010 470.739.000 16.23%
2011 469.629.000 -0.24%
2012 408.250.000 -15.03%
2013 310.340.000 -31.55%
2014 331.802.000 6.47%
2015 312.691.000 -6.11%
2016 322.414.000 3.02%
2017 353.935.000 8.91%
2018 393.902.000 10.15%
2019 404.158.000 2.54%
2020 332.600.000 -21.51%
2021 464.117.000 28.34%
2022 329.905.000 -40.68%
2023 327.820.000 -0.64%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Dolby Laboratories, Inc. Gross Profit
Year Gross Profit Growth
2001 74.211.000
2002 104.151.000 28.75%
2003 143.829.000 27.59%
2004 197.536.000 27.19%
2005 247.749.000 20.27%
2006 315.500.000 21.47%
2007 407.763.000 22.63%
2008 572.454.000 28.77%
2009 654.735.000 12.57%
2010 790.898.000 17.22%
2011 844.334.000 6.33%
2012 834.237.000 -1.21%
2013 812.955.000 -2.62%
2014 890.000.000 8.66%
2015 872.614.000 -1.99%
2016 916.756.000 4.82%
2017 963.147.000 4.82%
2018 1.043.664.000 7.71%
2019 1.080.766.000 3.43%
2020 1.015.294.000 -6.45%
2021 1.151.231.000 11.81%
2022 1.112.433.000 -3.49%
2023 1.020.040.000 -9.06%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Dolby Laboratories, Inc. Net Profit
Year Net Profit Growth
2001 5.651.000
2002 -105.000 5481.9%
2003 30.969.000 100.34%
2004 39.842.000 22.27%
2005 52.293.000 23.81%
2006 89.549.000 41.6%
2007 142.831.000 37.3%
2008 199.458.000 28.39%
2009 242.991.000 17.92%
2010 283.447.000 14.27%
2011 309.267.000 8.35%
2012 264.302.000 -17.01%
2013 189.271.000 -39.64%
2014 206.103.000 8.17%
2015 179.335.000 -14.93%
2016 185.860.000 3.51%
2017 201.802.000 7.9%
2018 122.246.000 -65.08%
2019 255.151.000 52.09%
2020 231.363.000 -10.28%
2021 310.227.000 25.42%
2022 184.087.000 -68.52%
2023 36.744.000 -401%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Dolby Laboratories, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 1 0%
2006 1 0%
2007 1 100%
2008 2 0%
2009 2 50%
2010 3 0%
2011 3 0%
2012 2 0%
2013 2 -100%
2014 2 50%
2015 2 -100%
2016 2 0%
2017 2 0%
2018 1 0%
2019 3 50%
2020 2 0%
2021 3 33.33%
2022 2 -200%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Dolby Laboratories, Inc. Free Cashflow
Year Free Cashflow Growth
2003 32.892.000
2004 34.336.000 4.21%
2005 65.688.000 47.73%
2006 124.463.000 47.22%
2007 147.170.000 15.43%
2008 250.864.000 41.33%
2009 249.660.000 -0.48%
2010 288.991.000 13.61%
2011 356.326.000 18.9%
2012 222.098.000 -60.44%
2013 243.900.000 8.94%
2014 244.879.000 0.4%
2015 114.422.000 -114.01%
2016 135.057.000 15.28%
2017 266.184.000 49.26%
2018 266.845.000 0.25%
2019 214.138.000 -24.61%
2020 274.862.000 22.09%
2021 393.299.000 30.11%
2022 259.120.000 -51.78%
2023 76.830.000 -237.26%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Dolby Laboratories, Inc. Operating Cashflow
Year Operating Cashflow Growth
2003 39.642.000
2004 46.858.000 15.4%
2005 80.422.000 41.73%
2006 132.502.000 39.31%
2007 162.973.000 18.7%
2008 264.474.000 38.38%
2009 273.225.000 3.2%
2010 327.298.000 16.52%
2011 403.688.000 18.92%
2012 389.797.000 -3.56%
2013 274.661.000 -41.92%
2014 371.137.000 25.99%
2015 309.390.000 -19.96%
2016 356.839.000 13.3%
2017 371.051.000 3.83%
2018 352.202.000 -5.35%
2019 327.674.000 -7.49%
2020 343.849.000 4.7%
2021 447.753.000 23.21%
2022 318.576.000 -40.55%
2023 85.015.000 -274.73%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Dolby Laboratories, Inc. Capital Expenditure
Year Capital Expenditure Growth
2003 6.750.000
2004 12.522.000 46.09%
2005 14.734.000 15.01%
2006 8.039.000 -83.28%
2007 15.803.000 49.13%
2008 13.610.000 -16.11%
2009 23.565.000 42.24%
2010 38.307.000 38.48%
2011 47.362.000 19.12%
2012 167.699.000 71.76%
2013 30.761.000 -445.17%
2014 126.258.000 75.64%
2015 194.968.000 35.24%
2016 221.782.000 12.09%
2017 104.867.000 -111.49%
2018 85.357.000 -22.86%
2019 113.536.000 24.82%
2020 68.987.000 -64.58%
2021 54.454.000 -26.69%
2022 59.456.000 8.41%
2023 8.185.000 -626.4%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Dolby Laboratories, Inc. Equity
Year Equity Growth
2001 60.645.000
2003 93.775.000 35.33%
2004 143.327.000 34.57%
2005 461.139.000 68.92%
2006 594.288.000 22.4%
2007 797.156.000 25.45%
2008 1.049.253.000 24.03%
2009 1.341.108.000 21.76%
2010 1.494.679.000 10.27%
2011 1.663.513.000 10.15%
2012 1.720.269.000 3.3%
2013 1.481.110.000 -16.15%
2014 1.710.017.000 13.39%
2015 1.805.013.000 5.26%
2016 1.970.256.000 8.39%
2017 2.136.742.000 7.79%
2018 2.189.551.000 2.41%
2019 2.307.351.000 5.11%
2020 2.432.643.000 5.15%
2021 2.597.979.000 6.36%
2022 2.246.183.000 -15.66%
2023 2.372.184.000 5.31%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Dolby Laboratories, Inc. Assets
Year Assets Growth
2001 125.635.000
2003 202.707.000 38.02%
2004 261.866.000 22.59%
2005 586.277.000 55.33%
2006 739.288.000 20.7%
2007 991.697.000 25.45%
2008 1.336.146.000 25.78%
2009 1.581.315.000 15.5%
2010 1.711.772.000 7.62%
2011 1.884.387.000 9.16%
2012 1.960.798.000 3.9%
2013 1.737.945.000 -12.82%
2014 1.984.012.000 12.4%
2015 2.133.293.000 7%
2016 2.310.106.000 7.65%
2017 2.533.554.000 8.82%
2018 2.659.269.000 4.73%
2019 2.821.749.000 5.76%
2020 2.917.325.000 3.28%
2021 3.105.687.000 6.07%
2022 2.689.548.000 -15.47%
2023 2.979.766.000 9.74%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Dolby Laboratories, Inc. Liabilities
Year Liabilities Growth
2001 0
2003 92.802.000 100%
2004 101.339.000 8.42%
2005 106.874.000 5.18%
2006 125.089.000 14.56%
2007 172.262.000 27.38%
2008 264.795.000 34.95%
2009 218.210.000 -21.35%
2010 217.093.000 -0.51%
2011 199.037.000 -9.07%
2012 217.565.000 8.52%
2013 237.919.000 8.56%
2014 252.364.000 5.72%
2015 319.341.000 20.97%
2016 331.371.000 3.63%
2017 389.712.000 14.97%
2018 463.151.000 15.86%
2019 508.719.000 8.96%
2020 478.920.000 -6.22%
2021 501.455.000 4.49%
2022 438.528.000 -14.35%
2023 607.582.000 27.82%

Dolby Laboratories, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
13.58
Net Income per Share
2.1
Price to Earning Ratio
40.82x
Price To Sales Ratio
6.26x
POCF Ratio
22.32
PFCF Ratio
24.16
Price to Book Ratio
3.48
EV to Sales
5.73
EV Over EBITDA
19.67
EV to Operating CashFlow
20.27
EV to FreeCashFlow
22.1
Earnings Yield
0.02
FreeCashFlow Yield
0.04
Market Cap
8,14 Bil.
Enterprise Value
7,44 Bil.
Graham Number
34.07
Graham NetNet
6.56

Income Statement Metrics

Net Income per Share
2.1
Income Quality
1.82
ROE
0.09
Return On Assets
0.07
Return On Capital Employed
0.07
Net Income per EBT
0.8
EBT Per Ebit
1.31
Ebit per Revenue
0.15
Effective Tax Rate
0.19

Margins

Sales, General, & Administrative to Revenue
0.2
Research & Developement to Revenue
0.21
Stock Based Compensation to Revenue
0.09
Gross Profit Margin
0.88
Operating Profit Margin
0.15
Pretax Profit Margin
0.19
Net Profit Margin
0.15

Dividends

Dividend Yield
0.01
Dividend Yield %
1.3
Payout Ratio
0.52
Dividend Per Share
1.11

Operating Metrics

Operating Cashflow per Share
3.84
Free CashFlow per Share
3.52
Capex to Operating CashFlow
-0.08
Capex to Revenue
-0.02
Capex to Depreciation
-0.32
Return on Invested Capital
0.06
Return on Tangible Assets
0.08
Days Sales Outstanding
124.79
Days Payables Outstanding
50.06
Days of Inventory on Hand
85.22
Receivables Turnover
2.92
Payables Turnover
7.29
Inventory Turnover
4.28
Capex per Share
-0.32

Balance Sheet

Cash per Share
9,24
Book Value per Share
24,61
Tangible Book Value per Share
18.77
Shareholders Equity per Share
24.61
Interest Debt per Share
0.89
Debt to Equity
0.02
Debt to Assets
0.02
Net Debt to EBITDA
-1.84
Current Ratio
3.52
Tangible Asset Value
1,80 Bil.
Net Current Asset Value
0,88 Bil.
Invested Capital
0.02
Working Capital
1,07 Bil.
Intangibles to Total Assets
0.19
Average Receivables
0,45 Bil.
Average Payables
0,02 Bil.
Average Inventory
34010500
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Dolby Laboratories, Inc. Dividends
Year Dividends Growth
2012 4
2014 0 0%
2015 0 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 1 0%
2022 1 100%
2023 1 0%

Dolby Laboratories, Inc. Profile

About Dolby Laboratories, Inc.

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

CEO
Mr. Kevin J. Yeaman
Employee
2.246
Address
1275 Market Street
San Francisco, 94103-1410

Dolby Laboratories, Inc. Executives & BODs

Dolby Laboratories, Inc. Executives & BODs
# Name Age
1 Mr. Peter L. Goldmacher
Vice President of Investor Relations
70
2 Mr. Kevin J. Yeaman
President, Chief Executive Officer & Director
70
3 Mr. Craig Todd
Chief Technology Officer & Senior Vice President
70
4 Mr. Robert J. Park
Senior Vice President & Chief Financial Officer
70
5 Mr. Ryan Nicholson
Vice President, Corporate Controller & Chief Accounting Officer
70
6 Mr. Ioan Allen
Senior Vice President
70
7 Mr. Andy Sherman
Executive Vice President, General Counsel & Corporate Secretary
70
8 Mr. John D. Couling
Senior Vice President of Entertainment
70
9 Ms. Linda Rogers
Senior Vice President & Chief People Officer
70
10 Mr. Todd Pendleton
Senior Vice President & Chief Marketing Officer
70

Dolby Laboratories, Inc. Competitors